Targeting DNA repair by coDbait enhances melanoma targeted radionuclide therapy

Oncotarget. 2016 Mar 15;7(11):12927-36. doi: 10.18632/oncotarget.7340.


Radiolabelled melanin ligands offer an interesting strategy for the treatment of disseminated pigmented melanoma. One of these molecules, ICF01012 labelled with iodine 131, induced a significant slowing of melanoma growth. Here, we have explored the combination of [131I]ICF01012 with coDbait, a DNA repair inhibitor, to overcome melanoma radioresistance and increase targeted radionuclide therapy (TRT) efficacy. In human SK-Mel 3 melanoma xenograft, the addition of coDbait had a synergistic effect on tumor growth and median survival. The anti-tumor effect was additive in murine syngeneic B16Bl6 model whereas coDbait combination with [131I]ICF01012 did not increase TRT side effects in secondary pigmented tissues (e.g. hair follicles, eyes). Our results confirm that DNA lesions induced by TRT were not enhanced with coDbait association but, the presence of micronuclei and cell cycle blockade in tumor shows that coDbait acts by interrupting or delaying DNA repair. In this study, we demonstrate for the first time, the usefulness of DNA repair traps in the context of targeted radionuclide therapy.

Keywords: DNA repair; coDbait; melanoma; targeted radionuclide therapy.

MeSH terms

  • Animals
  • Antineoplastic Combined Chemotherapy Protocols / pharmacology*
  • DNA / pharmacology*
  • DNA Repair / drug effects*
  • Drug Synergism
  • Female
  • Humans
  • Iodine Radioisotopes / pharmacology
  • Male
  • Melanoma / pathology
  • Melanoma, Experimental / drug therapy*
  • Melanoma, Experimental / pathology
  • Mice
  • Mice, Inbred C57BL
  • Mice, Nude
  • Quinoxalines / pharmacology
  • Xenograft Model Antitumor Assays


  • Iodine Radioisotopes
  • N-(2-diethylaminoethyl)-6-iodoquinoxaline-2-carboxamide
  • Quinoxalines
  • DNA